Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Calliditas Therapeutics (CALT)
NASDAQ:CALT
Holding CALT?
Track your performance easily
CALT Stock Chart & Stats
Day’s Range$40 - $43
52-Week Range― - ―
Previous Close$40.16
Volume9.80K
Average Volume (3M)N/A
Market Cap
$1.09B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Calliditas Therapeutics News
PremiumCompany Announcements
Calliditas Therapeutics Sets Delisting Process
PremiumCompany Announcements
Calliditas Therapeutics Sees Strong Sales Growth
PremiumCompany Announcements
Calliditas Therapeutics’ Share Capital and Votes Increase
PremiumCompany Announcements
Calliditas’ Setanaxib Shows Promise in PBC Trial
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CALT FAQ
What was Calliditas Therapeutics’s price range in the past 12 months?
Currently, no data Available
What is Calliditas Therapeutics’s market cap?
Currently, no data Available
When is Calliditas Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Calliditas Therapeutics’s earnings last quarter?
Currently, no data Available
Is Calliditas Therapeutics overvalued?
According to Wall Street analysts Calliditas Therapeutics’s price is currently Overvalued.
Does Calliditas Therapeutics pay dividends?
Calliditas Therapeutics does not currently pay dividends.
What is Calliditas Therapeutics’s EPS estimate?
Calliditas Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Calliditas Therapeutics have?
Currently, no data Available
What happened to Calliditas Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Calliditas Therapeutics?
Currently, no hedge funds are holding shares in CALT
---
Calliditas Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
CALT Sentiment 100%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 4.8%
Last 30 Days ▼ 4.8%
Fundamentals
Return on Equity
-159.97%
Trailing 12-Months
Asset Growth
4.26%
Trailing 12-Months
Company Description
Calliditas Therapeutics
Calliditas Therapeutics AB operates as a specialty pharmaceutical company in Sweden. The company is engaged in the provision of pharmaceutical products for patients with niche indications. It is focused on the development and commercialization of the product candidate Nefecon intended for the treatment of patients with the inflammatory renal disease IgA nephropathy, a disease that causes chronic inflammation of the kidneys.
---
CALT Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---